The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Serial Casting and Physical Therapy in Children With Idiopathic Toe Walking

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT06010485
Recruitment Status : Not yet recruiting
First Posted : August 24, 2023
Last Update Posted : August 24, 2023
Sponsor:
Information provided by (Responsible Party):
Fatih Sultan Mehmet Training and Research Hospital

Brief Summary:
Children who continue to walk on their tiptoes after developing a heel-toe gait normally are diagnosed with idiopathic toe walking (ITW). The study's aim was to investigate the effects of serial casting and physical therapy on joint range of motion (ROM), toe walking severity, functional health and health-related quality of life, walking balance, and satisfaction from treatment in ITW, in comparison with the control group.

Condition or disease Intervention/treatment Phase
Idiopathic Toe Walking Other: Serial Casting Other: Exercise Not Applicable

Detailed Description:
Children with ITW aged 3-10 years are randomized into three groups: the serial casting group (n=10), the physical therapy group (n=10), and the wait-list control group (n=10). Patients with ankle contracture and previous interventions are excluded. The serial casting group is planned to receive intermittent serial casting once every three days for three weeks. The physical therapy group is planned to undergo three sessions per week for three weeks, consisting of stretching exercises, strengthening exercises, balance training, proprioception exercises, and walking on heels. The patients were assessed by blinded investigators at before treatment (BT), post-treatment (PT: 3th week), 1st month (1MPT), 3rd months (3MPT), and 6th months post-treatment (6MPT). To ensure ethical considerations, only control group was followed-up until the 1MPT.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Randomized, single blinded, controlled study
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Effect of Serial Casting and Physical Therapy on Ankle Range of Motion, Toe Walking Severity, Walking Balance, Functional Health Related Quality of Life in Children With Idiopathic Toe Walking
Estimated Study Start Date : September 1, 2023
Estimated Primary Completion Date : March 1, 2024
Estimated Study Completion Date : April 15, 2024

Arm Intervention/treatment
Active Comparator: Serial Casting
The serial casting group received intermittent serial casting once every three days for three weeks.
Other: Serial Casting
A short leg cast is applied to the serial casting group by an orthopedic specialist once every three days for three weeks.

Active Comparator: Exercise
The physical therapy group underwent three sessions per week for three weeks, consisting of stretching exercises, strengthening exercises, balance training, proprioception exercises, and walking on heels.
Other: Exercise
Stretching exercises, strengthening exercises, balance exercises, proprioception exercises, and heel walking exercises are applied to the physical therapy group for 3 weeks with a physiotherapist for 3 sessions a week.

No Intervention: Control Group
This group consists of the patients on the waitlist.



Primary Outcome Measures :
  1. Range of Motion (ROM) [ Time Frame: Day 0 ]
    Ankle dorsiflexion ROM with extended knee

  2. Range of Motion (ROM) [ Time Frame: 3rd week ]
    Ankle dorsiflexion ROM with extended knee

  3. Range of Motion (ROM) [ Time Frame: 7th week ]
    Ankle dorsiflexion ROM with extended knee

  4. Range of Motion (ROM) [ Time Frame: 15th week ]
    Ankle dorsiflexion ROM with extended knee

  5. Range of Motion (ROM) [ Time Frame: 27th week ]
    Ankle dorsiflexion ROM with extended knee

  6. Range of Motion (ROM) [ Time Frame: Day 0 ]
    Ankle dorsiflexion ROM with flexed knee

  7. Range of Motion (ROM) [ Time Frame: 3rd week ]
    Ankle dorsiflexion ROM with flexed knee

  8. Range of Motion (ROM) [ Time Frame: 7th week ]
    Ankle dorsiflexion ROM with flexed knee

  9. Range of Motion (ROM) [ Time Frame: 15th week ]
    Ankle dorsiflexion ROM with flexed knee

  10. Range of Motion (ROM) [ Time Frame: 27th week ]
    Ankle dorsiflexion ROM with flexed knee

  11. Toe Walking Severity Scale [ Time Frame: Day 0 ]

    The family is asked how long the child tiptoe walks during the day. The evaluation is as follows.

    Stage 1: Toe walking 76-100% of the time Stage 2: Toe walking 51-75% of the time Stage 3: Toe walking 26-50% of the time Stage 4: Toe walking 10-25% of the time Stage 5: Sole pressing but early heel lift (occasional toe gait <10%) Stage 6: Normal heel strike


  12. Toe Walking Severity Scale [ Time Frame: 3rd week ]

    The family is asked how long the child tiptoe walks during the day. The evaluation is as follows.

    Stage 1: Toe walking 76-100% of the time Stage 2: Toe walking 51-75% of the time Stage 3: Toe walking 26-50% of the time Stage 4: Toe walking 10-25% of the time Stage 5: Sole pressing but early heel lift (occasional toe gait <10%) Stage 6: Normal heel strike


  13. Toe Walking Severity Scale [ Time Frame: 7th week ]

    The family is asked how long the child tiptoe walks during the day. The evaluation is as follows.

    Stage 1: Toe walking 76-100% of the time Stage 2: Toe walking 51-75% of the time Stage 3: Toe walking 26-50% of the time Stage 4: Toe walking 10-25% of the time Stage 5: Sole pressing but early heel lift (occasional toe gait <10%) Stage 6: Normal heel strike


  14. Toe Walking Severity Scale [ Time Frame: 15th week ]

    The family is asked how long the child tiptoe walks during the day. The evaluation is as follows.

    Stage 1: Toe walking 76-100% of the time Stage 2: Toe walking 51-75% of the time Stage 3: Toe walking 26-50% of the time Stage 4: Toe walking 10-25% of the time Stage 5: Sole pressing but early heel lift (occasional toe gait <10%) Stage 6: Normal heel strike


  15. Toe Walking Severity Scale [ Time Frame: 27th week ]

    The family is asked how long the child tiptoe walks during the day. The evaluation is as follows.

    Stage 1: Toe walking 76-100% of the time Stage 2: Toe walking 51-75% of the time Stage 3: Toe walking 26-50% of the time Stage 4: Toe walking 10-25% of the time Stage 5: Sole pressing but early heel lift (occasional toe gait <10%) Stage 6: Normal heel strike



Secondary Outcome Measures :
  1. Pediatric Outcomes Data Collection Instrument (PODCI) [ Time Frame: Day 0 ]
    PODCI evaluates functional health status through an 86 item questionnaire. Scoring varies greatly due to the multiple weighted scores of some items, scores range from 0-3 for some items and 0-6 for others. The overall score comes from 4 functional assessment scores, a global function score, and a happiness score. These scores range from 0-100 with lower scores representing higher levels of disability.

  2. Pediatric Outcomes Data Collection Instrument (PODCI) [ Time Frame: 3rd week ]
    PODCI evaluates functional health status through an 86 item questionnaire. Scoring varies greatly due to the multiple weighted scores of some items, scores range from 0-3 for some items and 0-6 for others. The overall score comes from 4 functional assessment scores, a global function score, and a happiness score. These scores range from 0-100 with lower scores representing higher levels of disability.

  3. Pediatric Outcomes Data Collection Instrument (PODCI) [ Time Frame: 7th week ]
    PODCI evaluates functional health status through an 86 item questionnaire. Scoring varies greatly due to the multiple weighted scores of some items, scores range from 0-3 for some items and 0-6 for others. The overall score comes from 4 functional assessment scores, a global function score, and a happiness score. These scores range from 0-100 with lower scores representing higher levels of disability.

  4. Pediatric Outcomes Data Collection Instrument (PODCI) [ Time Frame: 15th week ]
    PODCI evaluates functional health status through an 86 item questionnaire. Scoring varies greatly due to the multiple weighted scores of some items, scores range from 0-3 for some items and 0-6 for others. The overall score comes from 4 functional assessment scores, a global function score, and a happiness score. These scores range from 0-100 with lower scores representing higher levels of disability.

  5. Pediatric Outcomes Data Collection Instrument (PODCI) [ Time Frame: 27th week ]
    PODCI evaluates functional health status through an 86 item questionnaire. Scoring varies greatly due to the multiple weighted scores of some items, scores range from 0-3 for some items and 0-6 for others. The overall score comes from 4 functional assessment scores, a global function score, and a happiness score. These scores range from 0-100 with lower scores representing higher levels of disability.

  6. Tandem Walk Test [ Time Frame: Day 0 ]
    The participants are asked to walk in a straight line with one foot just in front of the other (heel to toe), arms at their sides.

  7. Tandem Walk Test [ Time Frame: 3rd week ]
    The participants are asked to walk in a straight line with one foot just in front of the other (heel to toe), arms at their sides.

  8. Tandem Walk Test [ Time Frame: 7th week ]
    The participants are asked to walk in a straight line with one foot just in front of the other (heel to toe), arms at their sides.

  9. Tandem Walk Test [ Time Frame: 15th week ]
    The participants are asked to walk in a straight line with one foot just in front of the other (heel to toe), arms at their sides.

  10. Tandem Walk Test [ Time Frame: 27th week ]
    The participants are asked to walk in a straight line with one foot just in front of the other (heel to toe), arms at their sides.

  11. Visual Analog Scale [ Time Frame: 3rd week ]
    All participants are asked about satisfaction with treatment through a smiley face visual analog scale 'smiley face' visual analogue scale (0-10, 0 for full satisfaction)

  12. Visual Analog Scale [ Time Frame: 7th week ]
    All participants are asked about satisfaction with treatment through a smiley face visual analog scale 'smiley face' visual analogue scale (0-10, 0 for full satisfaction)

  13. Visual Analog Scale [ Time Frame: 15th week ]
    All participants are asked about satisfaction with treatment through a smiley face visual analog scale 'smiley face' visual analogue scale (0-10, 0 for full satisfaction)

  14. Visual Analog Scale [ Time Frame: 27th week ]
    All participants are asked about satisfaction with treatment through a smiley face visual analog scale 'smiley face' visual analogue scale (0-10, 0 for full satisfaction)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   3 Years to 10 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Aged 3-10 years
  2. Patients with idiopathic toe walking diagnosis
  3. To be evaluated by a pediatric neurologist, not to have abnormal findings in cranial and all spinal magnetic resonance imaging and electrophysiological examinations performed when deemed necessary, and creatinine kinase values are within normal limits ((Absence of any neurological, orthopedic or psychiatric pathology to explain the toe walking pattern (cerebral palsy, neuropathy, myopathy, autism, developmental disorders, etc.)

Exclusion Criteria:

  1. Have previously conservative or surgical treatment
  2. Presence of plantar flexion contracture

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06010485


Contacts
Layout table for location contacts
Contact: Esra Giray +905558134394 girayesra@hotmail.com
Contact: Özge İlleez +905326255684 ozgeilleez@hotmail.com

Locations
Layout table for location information
Turkey
Fatih Sultan Mehmet Trainig and Research Hospital
Istanbul, Turkey, 34752
Sponsors and Collaborators
Fatih Sultan Mehmet Training and Research Hospital
Investigators
Layout table for investigator information
Principal Investigator: Esra Giray Fatih Sultan Mehmet training and Research Hospital, Istanbul-Turkey
Publications:

Layout table for additonal information
Responsible Party: Fatih Sultan Mehmet Training and Research Hospital
ClinicalTrials.gov Identifier: NCT06010485    
Other Study ID Numbers: illeezozge
First Posted: August 24, 2023    Key Record Dates
Last Update Posted: August 24, 2023
Last Verified: August 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Fatih Sultan Mehmet Training and Research Hospital:
Idiopathic Toe Walking
Serial Casting
Exercise